Eprenetapopt
N/A
Report date: 2023/05/05 17:38:51
NME
Base Information
Drug NameEprenetapopt
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[18]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[8]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAprea Therapeutics Ab
China Registration ClassN/A
Develop Information
Inactive CompaniesThe University Of Texas MD Anderson Cancer Center
Active Indications +[10]
Inactive Indications +[8]
Other Information
ATC CodeN/A
Related LinksN/A